LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. FMHR [Internet]. 2026 Mar. 31 [cited 2026 Aug. 7];4(3):3196-217. Available from: https://fmhr.net/index.php/fmhr/article/view/3537